Skip to main content
Clinical Trials/NCT00248235
NCT00248235
Completed
Phase 2

Randomized Controlled Trial of Progressive Resistance Exercise Training for Spinal Accessory Neurapraxia/ Neurectomy in Head and Neck Cancer Survivors

University of Alberta1 site in 1 country64 target enrollmentSeptember 2005

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Head and Neck Neoplasms
Sponsor
University of Alberta
Enrollment
64
Locations
1
Primary Endpoint
Pain and dysfunction (baseline, 12 weeks, 6 months, 12 months)
Status
Completed
Last Updated
last year

Overview

Brief Summary

The purpose of this study is to investigate the effect of a progressive therapeutic exercise program on specific physical and functional deficits in the neck and shoulder region occurring as a result of head and neck cancer treatment.

Detailed Description

We will be conducting a randomized controlled trial to evaluate the effects of progressive resistance exercise training (PRET) on shoulder and neck dysfunction due to spinal accessory neurapraxia/ neurectomy in patients with head and neck cancer. Sixty-four head and neck cancer survivors will be randomly assigned to PRET or standard care. Participants assigned to the PRET group will exercise 3 times per week for 12 weeks. The goal of the exercise program will be to enhance scapular stability, and improve mobility and strength of the upper extremity. The resistance exercise program will be progressive in terms of the number of sets and repetitions performed, as well as amount lifted, depending on baseline strength levels and overall performance status. The primary outcomes for the study include pain and dysfunction, active and passive range of motion measures, strength and endurance testing, and quality of life. Nerve conduction testing and electromyography will be performed to assess/ monitor the status of the spinal accessory nerve and trapezius muscle function respectively.

Registry
clinicaltrials.gov
Start Date
September 2005
End Date
January 2009
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Squamous cell carcinoma of the oral cavity, oropharynx, larynx or hypopharynx OR squamous cell carcinoma metastatic to the neck from unknown primary site; probable occult mucosal origin in the head and neck
  • Surgical treatment includes radical neck dissection, modified radical neck dissection and other variants of functional/selective neck dissection
  • Karnofsky Performance Status greater than or equal to 60%
  • No evidence of residual cancer in the neck and no distant (M0) metastasis
  • Participants must have completed their head and neck cancer treatment

Exclusion Criteria

  • A history of shoulder or neck pathology unrelated to cancer treatment
  • Serious co-morbid medical illness or psychiatric illness

Outcomes

Primary Outcomes

Pain and dysfunction (baseline, 12 weeks, 6 months, 12 months)

Time Frame: baseline, 12 weeks, 6 months, 12 months

Active and passive range of motion (baseline, 12 weeks)

Time Frame: baseline, 12 weeks

Muscular strength and endurance (baseline, 12 weeks)

Time Frame: baseline, 12 weeks

Quality of life (baseline, 12 weeks, 6 months, 12 months)

Time Frame: baseline, 12 weeks, 6 months, 12 months

Secondary Outcomes

  • Nerve conduction testing (baseline, 12 weeks as indicated)(Baseline)
  • Anxiety, depression and fatigue (baseline, 12 weeks, 6 months, 12 months)(baseline, 12 weeks, 6 months, 12 months)
  • Electromyography (baseline, 12 weeks as indicated)(Baseline)

Study Sites (1)

Loading locations...

Similar Trials